Keyword Search
   


This site is intended for U.S.
residents only.
For Novartis Worldwide, Click here

Mailing List
Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only.

Dermatology Clinical Trials

About Dermatology

As the outer protective covering of the body, the skin is directly exposed to the environment, and so it's quite vulnerable to tumors, rashes, discolorations, burns, injuries, infections, and other disorders. And generalized diseases, such as diabetes or under-activity of the thyroid, are sometimes accompanied by skin changes that may, indeed, be the first sign of the condition. Easy access to the skin means it's relatively easy for the dermatologist to make a diagnosis. But successful treatment is often a more difficult problem.

Dermatology Clinical Trials at Novartis

Novartis Pharmaceuticals is focusing some of its research efforts in dermatology on new treatments for the following conditions:

Dermatitis
This condition is not a single disease, but covers those skin disorders in which inflammation is the main feature. As a result of inflammation, symptoms such as redness and itching are common. Small blisters may occur, which, because of scratching, become infected and weep. While corticosteroids have been mainstays in treating dermatitis, newer treatments are designed to replace steroids, because of their possible side effects.

Atopic dermatitis (Eczema)
A type of dermatitis also called atopic eczema, this is a hereditary condition, often triggered by environmental factors. The skin itches intensely and is dry and inflamed, with episodes of weeping, crusting, cracking, and scaling. It most often affects infants and young children, but it can continue into adulthood or even first occur later in life. The condition fluctuates, with exacerbations, or flares. The disease is associated with other so-called atopic disorders, such as hay fever and asthma.

Psoriasis
This is a fluctuating but persistent skin disease that gets its name from the Greek word for "itch." The skin is inflamed, with red, thickened areas bearing silvery scales; it's seen most often on the elbows, knees, scalp, and lower back. It may be so mild that people don't know they have it. At the other end of the spectrum, severe psoriasis may cover large areas of the body.


If you are interested in learning more about other disease areas or therapeutic areas of Novartis clinical research, please select from the list below.



Site Map | Contact Us | Clinical Trial Search | Mailing List | Clinical Trial FAQs
Participation FAQs | Clinical Trials Glossary | About Informed Consent
Novartis Medical and Clinical Research | Clinical Trial Links | How to use this System

Use of this Website is governed by the Terms of Use and Privacy Statement. Copyright 2008 Novartis Pharmaceuticals Corporation. All Rights Reserved.
Novartis Logo